FDA Inspection 1181399 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on Sep 29, 2022 in Lake Charles, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 29, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Lake Charles, LA (United States)